Company Introduction

Thank you for visiting EMPECS

EMPECS Medical Device Co., Ltd. is a leader in making high-quality diagnostic and medical devices accessible and affordable to people around the world.

We constantly strive to improve our products and processes, and as a result, we have registered technical patents in China, Korea, and the United States. Our research and development efforts span various fields such as biosensor technology, electrochemistry, and optical technology, and our cutting-edge results are applied to advance the performance and productivity of our products.

Investing in advanced technologies and facilities is at the core of our commitment to producing biosensor medical devices, such as blood glucose monitors and test strips, of the highest quality.

With a global presence in around 80 countries and expanding, we share our expertise with our customers, delivering user-friendly products and services that are both competitively priced and reliable in quality. Our business philosophy of 'Customer First' puts our customers at the forefront, and we pride ourselves on fulfilling their needs and expectations.

At EMPECS, our dedication to complete customer satisfaction is unwavering. We aim to become a leading global healthcare company through continued research and development in the field of in vitro diagnostic medical devices, while maintaining the highest standards of product and service quality.



  • Acquired MFDS approval for ASUREQUAN COVID-19 Ag Test in Korea
  • CE Declaraion of Conformity for the COVID-19 Ag Rapid Test
  • Launching Multi functional meter
    (Glucose + Ketone + Total cholesterol + Uric acid)


  • Acquired MFDS approval for HbA1c Analyzer and Cartridge in Korea
  • Obtained CE certificate, Launched HbA1c Analyzer and Cartridge - ASUREQUAN
  • Obtained CE certificate, for Ketone, Dual meter (Ketone + Glucose), GX/GH series


  • Acquired ISO 13485:2016, CE certificate in Korea
  • Acquired ANVISA approval for BGMS - "MM1000 / GH81" series
  • Launched BGMS for animal use - Medisign-pet 83


  • Acquired ISO 13485:2016, CE certificate in China


  • Launched BGMS - "GH81 / GH81 BT / MM1000 BT" series and Cleared by FDA 510(k)
  • Completed the Plant expansion for BGMS in Tianjin, China
  • Acquired KGMP - GH81 series in Korea


  • Launched BGMS - MM3000 series and Cleared by FDA 510(k)
  • Acquired KGMP - MM1000 series in Korea


  • Launched BGMS - MM1000 series and Cleared by FDA 510(k)


  • Launched BGMS - MM200, MM600 series


  • Established R&D Lab in Korea
  • Completed the Plant for Blood Glucose Monitoring System(BGMS) in Tianjin, China
  • Acquired CFDA approval, CE certificate in China
  • Launched BGMS – MM800 series


  • Founded Tianjin Empecs Medical Device Co., Ltd. in China


Korea Head Office

  • location_onRm.701-707, SKn TechnoPark Mega-dong, 124, Sagimakgol-ro, Jungwon-gu, Seongnam-si, Gyeonggi-do, 13207 Republic of Korea
  • call(+82) 31 776 4489
  • fax(+82) 31 776 4496

China Factory

  • location_onNo.35 and 37, Yingcheng Street, Hangu,
    Binhai New Area, Tianjin, 300480
    People’s Republic of China.
  • call(+86) 22 2569 6839
  • fax(+86) 22 2569 1103

Beijing Office

  • location_onRm.801, No.9 Building Caimanjie, #67 GaojingChaoyang District, Beijing, 100123 People’s Republic of China.
  • call(+86) 10 8578 5529
  • fax(+86) 10 8578 5526

U.S.A. Office

  • location_on111 Roosevelt Avenue, Suite E
    Mineola, New York 11501
  • call(+1) 516 747 5730
  • fax(+1)516 739 8679